Allergen immunotherapy for the prevention of allergy: A systematic review and meta-analysis

Pediatric Allergy and Immunology

Volumn 28, Issue 1, 2017, Pages 18-29

  Kristiansen, Maria ^a   Dhami, Sangeeta ^b   Netuveli, Gopal ^c   Halken, Susanne ^d   Muraro, Antonella ^e   Roberts, Graham ^f,g,h   Larenas Linnemann, Desiree ⁱ   Calderón, Moises A ^j   Penagos, Martin ^j   Du Toit, George ^k,l   Ansotegui, Ignacio J ^m   Kleine Tebbe, Jörg ⁿ   Lau, Susanne ^o   Matricardi, Paolo Maria ^o   Pajno, Giovanni ^p   Papadopoulos, Nikolaos G ^q,r   Pfaar, Oliver ^s,t   Ryan, Dermot ^u   Santos, Alexandra F ^j   Timmermanns, Frans ^v   Wahn, Ulrich ^o   Sheikh, Aziz ^u   more..

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Evidence Based Health Care Ltd   (United Kingdom)

^c UNIVERSITY OF EAST LONDON   (United Kingdom)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

^e UNIVERSITY OF PADOVA   (Italy)

^f ST MARY S HOSPITAL   (United Kingdom)

^g UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^h UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

ⁱ Hospital Medica Sur   (Mexico)

^j ROYAL BROMPTON HOSPITAL   (United Kingdom)

^k KING'S COLLEGE LONDON   (United Kingdom)

^l GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^m Hospital Quirónsalud   (Spain)

ⁿ Allergie and Asthma Zentrum Westend   (Germany)

^o CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^p UNIVERSITY OF MESSINA   (Italy)

^q UNIVERSITY OF MANCHESTER   (United Kingdom)

^r UNIVERSITY OF ATHENS   (Greece)

^s UNIVERSITY OF HEIDELBERG   (Germany)

^t Centre for Rhinology and Allergology   (Germany)

^u UNIVERSITY OF EDINBURGH   (United Kingdom)

^v Netherlands Anaphylaxis Network   (Netherlands)

more..

Author keywords

allergen immunotherapy; allergic diseases; allergy; atopy; prevention; sensitization

Indexed keywords

ALLERGEN; HOUSE DUST ALLERGEN; MESOGLYCAN; POLLEN ANTIGEN;

ALLERGEN IMMUNOTHERAPY; ALLERGIC DISEASE; ALLERGIC RHINITIS; ALLERGY; ARTICLE; ASTHMA; ATOPIC DERMATITIS; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG SAFETY; ECZEMA; FOOD ALLERGY; HUMAN; IMMUNOTHERAPY; LONG TERM CARE; META ANALYSIS; PRIMARY PREVENTION; PRIORITY JOURNAL; PRURITUS; QUALITY CONTROL; QUASI EXPERIMENTAL STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIVITY ANALYSIS; SENSITIZATION; SUBLINGUAL IMMUNOTHERAPY; SYSTEMATIC REVIEW; TREATMENT OUTCOME; WHEEZING; ANIMAL; COST BENEFIT ANALYSIS; DESENSITIZATION; HYPERSENSITIVITY; IMMUNOLOGY; PROCEDURES; RHINITIS; RISK;

ANIMALS; ASTHMA; COST-BENEFIT ANALYSIS; DESENSITIZATION, IMMUNOLOGIC; HUMANS; HYPERSENSITIVITY; RHINITIS; RISK;

EID: 85010644766     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/pai.12661     Document Type: Article

References (43)

1. Ferdousi HA, Zetterström O, Dreborg S. Bronchial hyper-responsiveness predicts the development of mild clinical asthma within 2 yr in school children with hay-fever. Pediatr Allergy Immunol 2005: 16: 478–86.
2. Burgess JA, Walters EH, Byrnes GB, et al. Childhood allergic rhinitis predicts asthma incidence and persistence to middle age: a longitudinal study. J Allergy Clin Immunol 2007: 120: 863–9.
3. Jacobsen L, Niggermann B, Dreborg S, et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy 2007: 62: 943–8.
4. Jacobsen L, Petersen BN, Wihl JA, Lowenstein H, Ipsen H. Immunotherapy with partially purified and standardized tree pollen extracts. Results from long-term (6 year) follow-up. Allergy 1997: 52: 914–20.
5. Nieto A, Wahn U, Bufe A, et al. Allergy and asthma prevention 2014. Pediatr Allergy Immunol 2014: 25: 516–33.
6. Roches AD, Paradis L, Menardo J-L, Bouges S, Daurés J-P, Bousquet J. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children. J Allergy Clin Immunol 1997: 99: 450–3.
7. Purello-D'Ambrosio F, Gangemi S, Merendino RA, et al. Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study. Clin Exp Allergy 2001: 31: 1295–302.
8. Zolkipli Z, Roberts G, Cornelius V, et al. Randomized controlled trial of primary prevention of atopy using house dust mite allergen oral immunotherapy in early childhood. J Allergy Clin Immunol 2015: 136: 1541–7.
9. Dhami S, Nurmatov U, Halken S, et al. Allergen immunotherapy for the prevention of allergic disease: protocol for a systematic review. Pediatr Allergy Immunol 2016: 27: 236–41.
10. Passalacqua G, Baena-Cagnani CE, Bousquet J, et al. Grading local side effects of sublingual immunotherapy forrespiratory allergy: speaking the same language. J Allergy Clin Immunol 2013: 132: 93–8.
11. Cox L, Larenas-Linnemann D, Lockey RF, Passalacqua G. Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System. J Allergy Clin Immunol 2010: 125: 569–74.
12. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994: 50: 1088–101.
13. Holt PG, Sly PD, Sampson HA, et al. Prophylactic use of sublingual allergen immunotherapy in high-risk children: a pilot study. J Allergy Clin Immunol 2013: 132: 991–3.
14. Valovirta E, Berstad AK, de Blic J, et al. Design and recruitment for the GAP trial, investigating the preventive effect on asthma development of an SQ-standardized grass allergy immunotherapy tablet in children with grass pollen-induced allergic rhinoconjunctivitis. Clin Ther 2011: 33: 1537–46.
15. Clinical trial results: GAP - Grazax Asthma Prevention GAP investigators. 2016. https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-011235-12/results.
16. Schmitt J, Schwarz K, Stadler E, Wüstenberg EG. Allergy immunotherapy for allergic rhinitis effectively prevents asthma: results from a large retrospective cohort study. J Allergy Clin Immunol 2015: 136: 1511–6.
17. Song W, Lin X, Chai R. Efficacy evaluation of standardized dust mite allergen specific immunotherapy to patients of allergic rhinitis. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2014: 28: 300–2.
18. Crimi N, Li Gotti F, Mangano G, et al. A randomized, controlled study of specific immunotherapy in monosensitized subjects with seasonal rhinitis: effect on bronchial hyperresponsiveness, sputum inflammatory markers and development of asthma symptoms. Ann Ital Med Int 2004: 19: 98–108.
19. Grembiale RD, Camporota L, Naty S, Tranfa CME, Djukanovic R, Marsico SA. Effects of specific immunotherapy in allergic rhinitic individuals with bronchial hyperresponsivenes. Am J Respir Crit Care Med 2000: 162: 2048–52.
20. Möller C, Dreborg S, Ferdousi HA, et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-Study). J Allergy Clin Immunol 2002: 109: 251–6.
21. Niggemann B, Jacobsen L, Dreborg S, et al. Five-year follow-up on the PAT study: specific immunotherapy and long-term prevention of asthma in children. J Allergy Clin Immunol 2006: 61: 855–9.
22. Marogna M, Tomassetti D, Bernasconi A, et al. Preventive effects of sublingual immunotherapy in childhood: an open randomized controlled study. Ann Allergy Asthma Immunol 2008: 101: 206–11.
23. Möller C, Dreborg S, Lanner Å, Björkstén B. Oral immunotherapy of children with rhinoconjunctivitis due to birch pollen allergy. A double blind study. J Allergy Clin Immunol 1986: 41: 271–9.
24. Novembre E, Galli E, Landi F, et al. Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 2004: 114: 851–7.
25. Yamanaka K, Shah SA, Sakaida A, Masuda S, Mizutani H, Takeuchi K. Immunological parameters in prophylactic sublingual immunotherapy in asymptomatic subjects sensitized to Japanese cedar pollen. Allergol Int 2015: 64: 54–9.
26. Asero R. Injection immunotherapy with different airborne allergens did not prevent de novo sensitization to ragweed and birch pollen north of Milan. Int Arch Allergy Immunol 2004: 133: 49–54.
27. Di Rienzo V, Marcucci F, Puccinelli P, et al. Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study. Clin Exp Allergy 2003: 33: 206–10.
28. Dominicus R. 3-years' long-term effect of subcutaneous immunotherapy (SCIT) with a high-dose hypoallergenic 6-grass pollen preparation in adults. Eur Ann Allergy Clin Immunol 2012: 44: 135–40.
29. Eng PA, Borer-Reinhold M, Heijnen IAFM, Gnehm HPE. Twelve-year follow-up after discontinuation of preseasonal grass pollen immunotherapy in childhood. J Allergy Clin Immunol 2006: 61: 198–201.
30. Eng PA, Reinhold M, Gnehm HPE. Long-term efficacy of preseasonal grass pollen immunotherapy in children. J Allergy Clin Immunol 2002: 57: 306–12.
31. Garcia BE, González-Mancebo E, Barbar D, et al. Sublingual immunotherapy in peach allergy: monitoring molecular sensitizations and reactivity to apple fruit and Platanus pollen. J Investig Allergol Clin Immunol 2010: 20: 514–20.
32. Gulen F, Zeyrek D, Can D, et al. Development of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. Asian Pac J Allergy Immunol 2007: 25: 7–11.
33. Harmanci K, Razi CH, Toyran M, Kanmaz G, Cengizlier MR. Evaluation of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. Asian Pac J Allergy Immunol 2010: 28: 7–13.
34. Inal A, Altinas DU, Yilmaz M, Karakoc GB, Kendirli SG, Sertdemir Y. Prevention of new sensitizations by specific immunotherapy in children with rhinitis and/or asthma monosensitized to house dust mite. J Investig Allergol Clin Immunol 2007: 17: 85–91.
35. Limb SL, Brown KC, Wood RA, Eggleston PA, Hamilton RG, Adkinson NF Jr. Long-term immunologic effects of broad-spectrum aeroallergen immunotherapy. Int Arch Allergy Immunol 2006: 140: 245–51.
36. Marogna M, Spadolini I, Massolo A, Canonica GW, Passalacqua G. Randomized controlled open study of sublingual immunotherapy for respiratory allergy in real-life: clinical efficacy and more. J Allergy Clin Immunol 2004: 59: 1205–10.
37. Marogna M, Spadolini I, Massolo A, Canonica GW, Passalacqua G. Long-lasting effects of sublingual immunotherapy according to its duration: a 15-year prospective study. J Allergy Clin Immunol 2010: 126: 969–75.
38. Ohashi Y, Nakai Y. Immunotherapy for cure and prophylaxis of allergic rhinitis. Clin Exp Allergy Rev 2009: 9: 6–10.
39. Pajno GB, Barberio G, De Luca FR, Morabito L, Parmiani S. Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. Clin Exp Allergy 2001: 31: 1392–7.
40. Pifferi M, Baldini G, Marrazzini G, et al. Benefits of immunotherapy with a standardized Dermatophagoides pteronyssinus extract in asthmatic children: a three-year prospective study. J Allergy Clin Immunol 2002: 57: 785–90.
41. Reha CM, Ebru A. Specific immunotherapy is effective in the prevention of new sensitivities. Allergol Immunopathol (Madr) 2007: 35: 44–51.
42. Szépfalusi Z, Bannert C, Ronceray L, et al. Preventive sublingual immunotherapy in preschool children: first evidence for safety and pro-tolerogenic effects. Pediatr Allergy Immunol 2014: 25: 788–95.
43. Tella R, Bartra J, San Miguel M, et al. Effects of specific immunotherapy on the development of new sensitisations in monosensitised patients. Allergol Immunopathol (Madr) 2003: 31: 221–5.